Interpace Biosciences, Inc. Made Big Gain
Wed, Oct 14, 2020 at 05:30 PM
Interpace Biosciences, Inc. (IDXG:NASDAQ) rocketted at $3.96, a gain of 32.9%. The stock got featured on our News Catalysts scanner on Wed 14 Oct 20 at 09:18 AM in the 'INVESTOR UPDATE' category. From Tue 29 Sep 20, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Fri 24 Jul 20 at $8.32 with a volume of 4M+, and its share price has been moving sideways in recent weeks.
About Interpace Biosciences, Inc. (IDXG:NASDAQ)
Interpace Diagnostics Group Inc is engaged in developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for diagnosis and management.
Top 10 Gainers:
- Kaixin Auto Holdings (KXIN:NASDAQ), 260.92%
- Medalist Diversified REIT, Inc. (MDRR:NASDAQ), 147.83%
- Replimune Group, Inc. (REPL:NASDAQ), 46.82%
- Mmtec, Inc. (MTC:NASDAQ), 36.97%
- HUSN (HUSN:NASDAQ), 33.82%
- Interpace Biosciences, Inc. (IDXG:NASDAQ), 32.89%
- Allscripts Healthcare Solutions, Inc. (MDRX:NASDAQ), 31.17%
- VOXX International Corporation (VOXX:NASDAQ), 31.02%
- Senmiao Technology Limited (AIHS:NASDAQ), 24.18%
- Novan, Inc. (NOVN:NASDAQ), 24.13%